Clinical Trial Update: Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting efficacy and safety results for tezepelumab in adults with severe chronic rhinosinusitis with nasal polyps; results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | Status: COMPLETED | Results posted: 2026-01-27